Targeted Medical Pharma TRGM · USD

Its shares trade under the ticker TRGM. It has been listed since 10 September 2012. In the fiscal year to 31 December 2015, it reported revenue of $5.3m and a net loss of $3.0m. At that date it held total assets of $2.4m and shareholders' equity of −$12.9m.

Targeted Medical Pharma, Inc. is a medical nutrition company, which engages in the research, development, and commercialization of amino acid based medications. The company is headquartered in Los Angeles, California. The company went IPO on 2012-09-10. The firm develops and distributes a line of amino acid-based medical food products, dietary supplements and generic drugs to physicians, pharmacies and patients throughout the United States and abroad. The firm operates through TMP, Complete Claims Processing Inc. (CCPI) and Amino Nutritionals segments. TMP develops and distributes amino acid-based therapeutic products and distributes pharmaceutical products from other manufacturers. CCPI segment provides point-of-care dispensing solutions, and billing and collections services. Amino Nutritionals segment develops and distributes amino acid-based dietary supplements directly to consumers. Its products and services include Medical Foods, Medical foods and generic pharmaceuticals, and Billing and Collections.

Figures and description from our data supplier, not checked against the company's own report.

• Mr. Kerry WeemsNon-Executive Chairman of the Board, Director
• Ms. Marcus CharuvastraInterim Chief Executive Officer, Director
• Mr. Kim GiffoniExecutive Vice President - Foreign Sales, Director, since 1999$484,556
• Douglas GintzChief Technology Officer, since 2013$207,692
• Mr. Maurice DeWaldIndependent Director
• Dr. Thomas WenkartIndependent Director

Overall

0

Environment

0

Social

0

Governance

0

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.